Selçuk Erdem

1.3k total citations
73 papers, 695 citations indexed

About

Selçuk Erdem is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Selçuk Erdem has authored 73 papers receiving a total of 695 indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Pulmonary and Respiratory Medicine, 28 papers in Surgery and 19 papers in Molecular Biology. Recurrent topics in Selçuk Erdem's work include Renal cell carcinoma treatment (43 papers), Renal and related cancers (19 papers) and Bladder and Urothelial Cancer Treatments (17 papers). Selçuk Erdem is often cited by papers focused on Renal cell carcinoma treatment (43 papers), Renal and related cancers (19 papers) and Bladder and Urothelial Cancer Treatments (17 papers). Selçuk Erdem collaborates with scholars based in Türkiye, Italy and Belgium. Selçuk Erdem's co-authors include Öner Şanlı, Riccardo Campi, Tzevat Tefik, Eduard Roussel, Riccardo Bertolo, İşın Kiliçaslan, Nicola Pavan, Önder Kara, Halim İşsever and Alexandre Ingels and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Urology and European Urology.

In The Last Decade

Selçuk Erdem

65 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Selçuk Erdem Türkiye 15 411 185 144 122 109 73 695
Ridwan Alam United States 15 533 1.3× 284 1.5× 242 1.7× 57 0.5× 123 1.1× 72 773
Jae Young Joung South Korea 17 446 1.1× 211 1.1× 195 1.4× 48 0.4× 160 1.5× 82 818
Carmine D’Aniello Italy 17 350 0.9× 242 1.3× 239 1.7× 63 0.5× 147 1.3× 33 720
Martijn G. Steffens Netherlands 16 327 0.8× 275 1.5× 205 1.4× 250 2.0× 132 1.2× 54 867
Benjamin T. Ristau United States 14 471 1.1× 212 1.1× 326 2.3× 142 1.2× 127 1.2× 67 805
Marc‐Olivier Timsit France 21 613 1.5× 345 1.9× 360 2.5× 106 0.9× 150 1.4× 59 1.1k
Meritxell Mollà Spain 16 236 0.6× 126 0.7× 145 1.0× 230 1.9× 122 1.1× 49 719
S. Melchior Germany 11 380 0.9× 336 1.8× 139 1.0× 58 0.5× 149 1.4× 34 672
Ralph P. Ermoian United States 15 182 0.4× 220 1.2× 56 0.4× 140 1.1× 126 1.2× 55 680
Elie Antebi Israel 10 465 1.1× 261 1.4× 159 1.1× 40 0.3× 97 0.9× 23 696

Countries citing papers authored by Selçuk Erdem

Since Specialization
Citations

This map shows the geographic impact of Selçuk Erdem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Selçuk Erdem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Selçuk Erdem more than expected).

Fields of papers citing papers by Selçuk Erdem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Selçuk Erdem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Selçuk Erdem. The network helps show where Selçuk Erdem may publish in the future.

Co-authorship network of co-authors of Selçuk Erdem

This figure shows the co-authorship network connecting the top 25 collaborators of Selçuk Erdem. A scholar is included among the top collaborators of Selçuk Erdem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Selçuk Erdem. Selçuk Erdem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Re, Chiara, Angela Pecoraro, Grant D. Stewart, et al.. (2025). Genetic Testing and Counselling for Hereditary Renal Carcinoma: What Do Clinicians Need to Know?. European Urology Open Science. 82. 131–141. 1 indexed citations
3.
Erdem, Selçuk, et al.. (2024). Examination of parotid gland in diabetics with ultrasound elastography and microvascular imaging. Medicina oral, patología oral y cirugía bucal. 30(1). e117–e123. 1 indexed citations
4.
Marandino, Laura, Riccardo Bertolo, Alexandre Ingels, et al.. (2023). Artificial Intelligence in Renal Cell Carcinoma Histopathology: Current Applications and Future Perspectives. Diagnostics. 13(13). 2294–2294. 9 indexed citations
5.
Muselaers, Stijn, Daniele Amparore, Riccardo Bertolo, et al.. (2023). Optimizing postoperative follow-up in RCC patients: why does it always have to be black and white?. Minerva Urology and Nephrology. 74(6). 822–824. 5 indexed citations
6.
Roussel, Eduard, Riccardo Campi, Daniele Amparore, et al.. (2022). Expanding the Role of Ultrasound for the Characterization of Renal Masses. Journal of Clinical Medicine. 11(4). 1112–1112. 7 indexed citations
7.
Muselaers, Stijn, Selçuk Erdem, Riccardo Bertolo, et al.. (2022). PSMA PET/CT in Renal Cell Carcinoma: An Overview of Current Literature. Journal of Clinical Medicine. 11(7). 1829–1829. 24 indexed citations
8.
Oktar, Tayfun, Canan Küçükgergin, Muhammet İrfan Dönmez, et al.. (2022). Urinary HSP70 can predict the indication of surgery in unilateral ureteropelvic junction obstruction. Pediatric Surgery International. 38(3). 499–503.
10.
Karadeniz, Meltem Savran, et al.. (2022). Quadratus Lumborum Block with Laparoscopic Assisted Catheter Placement Technique in Donor Nephrectomy: A Preliminary Report. Transplantation Proceedings. 54(7). 1759–1762. 1 indexed citations
11.
Carbonara, Umberto, Daniele Amparore, Cosimo Gentile, et al.. (2022). Current strategies to diagnose and manage positive surgical margins and local recurrence after partial nephrectomy. Asian journal of urology. 9(3). 227–242. 6 indexed citations
12.
Kiremit, Murat Can, Ömer Acar, Selçuk Erdem, et al.. (2021). Quantitative Proteomics Identifies Secreted Diagnostic Biomarkers as well as Tumor-Dependent Prognostic Targets for Clear Cell Renal Cell Carcinoma. Molecular Cancer Research. 19(8). 1322–1337. 13 indexed citations
13.
Çakıcı, Mehmet Çağlar, Faruk Özgör, Selçuk Erdem, et al.. (2021). The clinical impact of the COVID-19 pandemic on daily urological practice: first 3-month multicenter results from İstanbul. TURKISH JOURNAL OF MEDICAL SCIENCES. 51(3). 962–971. 4 indexed citations
15.
Dönmez, Muhammet İrfan, Orhan Ziylan, Tayfun Oktar, et al.. (2020). Can urinary biomarkers detect obstruction defined by renal functional loss in antenatal hydronephrosis?. Journal of Pediatric Urology. 16(6). 844.e1–844.e7. 9 indexed citations
16.
Şanlı, Öner, Selçuk Erdem, Tzevat Tefik, et al.. (2017). The association between variant urothelial histologies, pathological stage and disease specific survival in patients with bladder cancer. SHILAP Revista de lepidopterología. 44(1). 24–30. 6 indexed citations
17.
Şanlı, Öner, Selçuk Erdem, & Tzevat Tefik. (2014). How to write a discussion section?. SHILAP Revista de lepidopterología. 39(-1). 20–24. 20 indexed citations
18.
Erdem, Selçuk, et al.. (2014). Increased preoperative levels of plasma fibrinogen and d dimer in patients with renal cell carcinoma is associated with poor survival and adverse tumor characteristics. Urologic Oncology Seminars and Original Investigations. 32(7). 1031–1040. 41 indexed citations
19.
Erdem, Selçuk, Öner Şanlı, Tzevat Tefik, et al.. (2012). Retroperitoneoscopic nephrectomy has better perioperative outcomes than transperitoneal laparoscopic nephrectomy in obese patients. SHILAP Revista de lepidopterología. 38(2). 80–87. 2 indexed citations
20.
Burak, Zeynep, Ahmet Memiş, Selçuk Erdem, et al.. (1994). Evaluation of palpable breast masses with 99Tcm-MIBI: a comparative study with mammography and ultrasonography. Nuclear Medicine Communications. 15(8). 604–612. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026